Principal Financial Group Inc Guardant Health, Inc. Transaction History

Principal Financial Group Inc

$167 Billion
Q1 2025

A detailed history of Principal Financial Group Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 498,129 shares of GH stock, worth $23.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

498,129

Previous 10,086 4838.82%

Holding current value

$23.5 Million

Previous $308,000 6789.61%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	BUY	$31.77 - $49.94 $15.5 Million - $24.4 Million	488,043 Added 4838.82%	498,129 $21.2 Million
Q4 2024 Jan 31, 2025	BUY	$20.2 - $38.11 $203,737 - $384,377	10,086 New	10,086 $308,000
Q3 2024 Oct 31, 2024	SELL	$22.3 - $36.29 $110,964 - $180,579	-4,976 Reduced 31.21%	10,966 $251,000
Q2 2024 Jul 29, 2024	SELL	$16.07 - $31.84 $3.41 Million - $6.76 Million	-212,273 Reduced 93.01%	15,942 $460,000
Q1 2024 Apr 29, 2024	BUY	$17.13 - $26.91 $3.69 Million - $5.79 Million	215,170 Added 1649.44%	228,215 $4.71 Million
Q4 2023 Feb 07, 2024	BUY	$21.58 - $29.5 $26,759 - $36,580	1,240 Added 10.5%	13,045 $352,000
Q3 2023 Nov 02, 2023	SELL	$25.8 - $39.97 $34,133 - $52,880	-1,323 Reduced 10.08%	11,805 $349,000
Q2 2023 Aug 07, 2023	BUY	$20.94 - $38.01 $56,914 - $103,311	2,718 Added 26.11%	13,128 $469,000
Q1 2023 May 09, 2023	SELL	$22.92 - $33.76 $44,602 - $65,696	-1,946 Reduced 15.75%	10,410 $244,000
Q4 2022 Feb 09, 2023	SELL	$25.44 - $59.78 $275,184 - $646,640	-10,817 Reduced 46.68%	12,356 $336,000
Q3 2022 Nov 09, 2022	SELL	$43.66 - $61.0 $74,658 - $104,310	-1,710 Reduced 6.87%	23,173 $1.25 Million
Q2 2022 Aug 10, 2022	BUY	$28.82 - $77.35 $124,646 - $334,538	4,325 Added 21.04%	24,883 $1 Million
Q1 2022 May 09, 2022	SELL	$48.25 - $100.49 $64,799 - $134,958	-1,343 Reduced 6.13%	20,558 $1.36 Million
Q4 2021 Feb 09, 2022	SELL	$88.71 - $120.43 $671,002 - $910,932	-7,564 Reduced 25.67%	21,901 $2.19 Million
Q3 2021 Nov 09, 2021	SELL	$98.77 - $132.17 $370,980 - $496,430	-3,756 Reduced 11.31%	29,465 $3.68 Million
Q2 2021 Aug 10, 2021	BUY	$109.77 - $165.68 $186,169 - $280,993	1,696 Added 5.38%	33,221 $4.13 Million
Q1 2021 May 10, 2021	BUY	$127.04 - $179.1 $120,942 - $170,503	952 Added 3.11%	31,525 $4.81 Million
Q4 2020 Feb 08, 2021	BUY	$99.96 - $135.93 $134,246 - $182,553	1,343 Added 4.59%	30,573 $3.94 Million
Q3 2020 Nov 06, 2020	SELL	$80.32 - $111.8 $169,234 - $235,562	-2,107 Reduced 6.72%	29,230 $3.27 Million
Q2 2020 Aug 05, 2020	BUY	$60.49 - $97.5 $1.03 Million - $1.66 Million	17,055 Added 119.42%	31,337 $2.54 Million
Q1 2020 May 12, 2020	BUY	$59.04 - $88.81 $35,660 - $53,641	604 Added 4.42%	14,282 $994,000
Q4 2019 Feb 05, 2020	BUY	$59.49 - $82.78 $20,821 - $28,973	350 Added 2.63%	13,678 $1.07 Million
Q3 2019 Nov 13, 2019	SELL	$62.59 - $110.3 $324,904 - $572,567	-5,191 Reduced 28.03%	13,328 $851,000
Q2 2019 Aug 12, 2019	BUY	$63.94 - $91.11 $1.18 Million - $1.69 Million	18,519 New	18,519 $1.6 Million

Others Institutions Holding GH

# of Institutions

365

Shares Held

118M

Call Options Held

793K

Put Options Held

1.85M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Guardant Health, Inc. Transaction History